Literature DB >> 22855766

Limited susceptibility of cynomolgus monkeys (Macaca fascicularis) to leprosy after experimental administration of Mycobacterium leprae.

Gerald P Walsh1, Eduardo C Dela Cruz, Rodolfo M Abalos, Esterlina V Tan, Tranquilino T Fajardo, Laarni G Villahermosa, Roland V Cellona, Maria V Balagon, Valerie A White, Paul R Saunderson, Douglas S Walsh.   

Abstract

Cynomolgus monkeys are a useful model for human tuberculosis, but susceptibility to M. leprae is unknown. A cynomolgus model of leprosy could increase understanding of pathogenesis-importantly, neuritis and nerve-damaging reactions. We administered viable Mycobacterium leprae to 24 cynomolgus monkeys by three routes, with a median follow-up period of 6 years (range = 1-19 years) involving biopsies, nasal smears, antiphenolic glycolipid-1 (PGL-1) antibody serology, and lepromin skin testing. Most developed evanescent papules at intradermal M. leprae inoculation sites that, on biopsy, showed a robust cellular immune response akin to a lepromin skin test reaction; many produced PGL-1 antibodies. At necropsy, four monkeys, without cutaneous or gross neurological signs of leprosy but with elevated PGL-1 antibodies, including three with nasal smears (+) for acid fast bacilli (AFB), showed histological features, including AFB, suggestive of leprosy at several sites. Overall, however, cynomolgus monkeys seem minimally susceptible to leprosy after experimental M. leprae administration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855766      PMCID: PMC3414572          DOI: 10.4269/ajtmh.2012.11-0780

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  31 in total

1.  Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy.

Authors:  S N Cho; R V Cellona; L G Villahermosa; T T Fajardo; M V Balagon; R M Abalos; E V Tan; G P Walsh; J D Kim; P J Brennan
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.

Authors:  B J Gormus; G B Baskin; K Xu; M S Ratterree; L N Martin; P A Mack; R P Bohm; W M Meyers; G P Walsh
Journal:  Int J Lepr Other Mycobact Dis       Date:  2000-03

3.  Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment of M. leprae infections in mice.

Authors:  C C Shepard
Journal:  Int J Lepr Other Mycobact Dis       Date:  1976 Jan-Jun

4.  The inoculation of human leprosy in the chimpanzee initiation of a long-term project.

Authors:  C H Binford
Journal:  Int J Lepr       Date:  1965 Jul-Sep

5.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

6.  Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.

Authors:  B J Gormus; G B Baskin; K Xu; M S Ratterree; L N Martin; P A Mack; R P Bohm; W M Meyers; G P Walsh
Journal:  Int J Lepr Other Mycobact Dis       Date:  2000-12

Review 7.  Leprosy.

Authors:  Warwick J Britton; Diana N J Lockwood
Journal:  Lancet       Date:  2004-04-10       Impact factor: 79.321

8.  Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28-induced signalling events: insights into T-cell unresponsiveness in leprosy.

Authors:  Pradeep K Dagur; Bhawna Sharma; Gavish Kumar; Naim A Khan; Vishwa M Katoch; Utpal Sengupta; Beenu Joshi
Journal:  Mol Immunol       Date:  2009-12-16       Impact factor: 4.407

9.  Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.

Authors:  B J Gormus; G B Baskin; K Xu; M S Ratterree; P A Mack; R P Bohm; W M Meyers; G P Walsh
Journal:  Lepr Rev       Date:  2002-09       Impact factor: 0.537

10.  Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.

Authors:  Roland V Cellona; Maria F V Balagon; Eduardo C dela Cruz; Jasmin A Burgos; Rodolfo M Abalos; Gerald P Walsh; Richard Topolski; Robert H Gelber; Douglas S Walsh
Journal:  Int J Lepr Other Mycobact Dis       Date:  2003-12
View more
  2 in total

Review 1.  On the age of leprosy.

Authors:  Xiang Y Han; Francisco J Silva
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13

2.  Leprosy: a review of laboratory and therapeutic aspects--part 2.

Authors:  Joel Carlos Lastória; Marilda Aparecida Milanez Morgado de Abreu
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.